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ZebraﬁshStressful manipulations can sensitize the behavior of an organism, increasing anxiety-like behavior after a delay;
this long-term stress sensitization can represent the pathophysiological basis of trauma- and stress-related disor-
ders (TRSDs), of which themost prevalent is post-traumatic stress disorder (PTSD). A role for the glutamate–nitric
oxide pathway in this sensitization is implied by behavioral, neurophysiological and genomic data on different
species. Here, we report on the long-term sensitization of anxiety-like behavior in zebraﬁsh and the possible
participation of nitric oxide in this process. Zebraﬁsh exposed to a conspeciﬁc alarm substance (AS) show increased
anxiety-like behavior at least 24 h after stimulus delivery. Blocking nitric oxide synthesis with L-NAME (5 mg/kg)
30 min, but not 90 min, after AS exposure blocks the sensitization of scototaxis and risk assessment, while treat-
ment 90min after exposure blocks the sensitization of thigmotaxis and erratic swimming; L-NAMEwas not effec-
tive when administered 30 min before AS exposure. These data suggest a participation of nitric oxide in the
consolidation, but not in the initiation, of behavioral sensitization after predator threat.
© 2015 Elsevier Inc. All rights reserved.1. Introduction
Stressful experiences can result in a plethora of long-term changes in
behavioral andphysiological responseswhich candevelop in trauma- and
stress-related (TSRD) psychiatric morbidities (Agaibi and Wilson, 2005).
While a rich literature on the effects of chronic homo- or heterotypic
stressors in animal models exists, it has been suggested that responses
to relatively brief and infrequent stressor exposure is more relevant to
these disorders (Yehuda and Antelman, 1993; Daskalakis et al., 2013).
In animals, different stressful manipulations (physical restraint, social
confrontations, footshocks, predator stress, drug withdrawal) have been
shown to produce a delayed sensitization of anxiety-like behavior
which may mimic the changes observed in humans (Stam, 2007b;
Cohen et al., 2012; Daskalakis et al., 2013; Matar et al., 2013). This long-as e Comportamento “Frederico
ências Fisiológicas, Centro de
do Pará, Campus VIII/Marabá,term stress sensitization increases anxiety-like behavior, alterations in au-
tonomic reactivity, hypocortisolemia andhypersensitivity of the hypotha-
lamic–pituitary–adrenal axis, and increased catecholaminemetabolism in
the brain (Stam et al., 2000; Stam, 2007a, 2007b). Stress sensitization un-
dergo processes of initiation and consolidation; for example, initiation,
but not consolidation, of the delayed effects of predator stress on rodent
behavior is NMDA receptor-dependent (Blundell et al., 2005), while con-
solidation involvesβ-noradrenergic, glucocorticoid andmineralocorticoid
receptors (Adamec et al., 2007) and 5-HT1A and 5-HT2A receptors
(Adamec et al., 2004a, 2004b).
The addition of other species in biological psychiatric research can
contribute towards our understanding of such phenomena (van der
Staay, 2006; Kalueff et al., 2008; Steimer, 2011). In this sense, zebraﬁsh
(Danio rerio Hamilton 1822) has appeared recently as a promising
model in neuropsychiatric studies (Norton and Bally-Cuif, 2010; Bren-
nan, 2011; Norton, 2013; Parker et al., 2013; Kalueff et al., 2014; Stewart
et al., 2014a; Gerlai, 2015). This species presents diverse behavioral and
physiological phenotypes that are sensitive to stress and anti-stress
drugs (Gerlai, 2010; Maximino et al., 2010b; Steenbergen et al., 2011;
Stewart et al., 2011), suggesting endpoints which could be assessed in
response to sustained stress (Stewart et al., 2014b) and long-term stress
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responses, the most well-suited to study long-term stress sensitization
are antipredatory responses, given their high translational relevance
(Gerlai, 2010). An importantmanipulation that elicits fear-like behavior
in zebraﬁsh is the conspeciﬁc alarm substance (AS), a mixture of com-
ponents released by epidermic club cells of conspeciﬁcs (von Frisch,
1938; Jesuthasan and Mathuru, 2008; Døving and Lastein, 2009;
Gerlai, 2010). In addition to increased cortisol responses (Cachat et al.,
2010;Mathuru et al., 2012), acute exposure to AS has been demonstrat-
ed to increase bottom-dwelling (Egan et al., 2009), shoal cohesion
(Speedie and Gerlai, 2008) and erratic movements in the novel tank
test and group behavior task (Speedie and Gerlai, 2008; Egan et al.,
2009; Mathuru et al., 2012), increase scototaxis (preference for dark-
ness) and freezing in the light/dark test (Mansur et al., 2014;
Maximino et al., 2014a), to promote analgesia in zebraﬁsh (Maximino,
2011; Lima et al., 2012; Maximino et al., 2014a).
The mechanisms which underlie this sensitization in mammals are
unknown. Some suggestions on the involvement of glutamate NMDA re-
ceptors arise from both experimental and clinical observations. Treat-
ment with NMDA receptor antagonists before, but not after, predator
stress blocks the behavioral sensitization (Blundell et al., 2005),
metaplasticity (Adamec et al., 2005), and upregulation of plasticity
markers in regions involved in defensive behavior in rodents (Blundell
and Adamec, 2007). Pretreatment with D-cycloserine (an agonist at the
glycineB site of NMDA receptors) blocks both the impairment in fear ex-
tinction and the upregulation in the expression of NMDA receptor sub-
units in the hippocampus of rats exposed to the single-prolonged
stress model of post-traumatic stress disorder (PTSD) (Yamamoto
et al., 2008). Finally, there is some evidence that D-cycloserine has
some clinical efﬁcacy in treating PTSD (Norberg et al., 2008).
Given that glutamatergic activation of the NMDA receptor leads to
calcium inﬂux followed by activation of a nitric oxide-guanylate cyclase
pathway in the brain (Garthwaite and Boulton, 1995; Garthwaite,
2008), it is possible that nitric oxide (NO) or its metabolites, nitrite
and nitrate, mediate long-term stress sensitization. Activation of the
nitrergic system has been shown to participate in neural plasticity asso-
ciated with aversive memories (Hopper and Garthwaite, 2006) as well
as in unconditioned responses to stress (Beijamini et al., 2005). Nitric
oxide-producing cells are enriched in regions of the limbic system
which organize defensive behavior in mammals (Vincent and Kimura,
1992; Wang et al., 1995; Matsushita et al., 2001; Simpson et al., 2003),
amphibians (López et al., 2005) and ﬁsh (Holmqvist et al., 2000, 2007;
Bordieri et al., 2005; Giraldez-Perez et al., 2008; Mueller et al., 2011).
In rodents, NO-guanylate cyclase pathway activation peaks immediate-
ly after inhibitory avoidance training and begins to decline one hour
after training (Izquierdo et al., 2006). Consistently, in zebraﬁsh treat-
mentwith the nitric oxide synthase inhibitor L-NAMEblocks the consol-
idation of active avoidance responses (Xu et al., 2007) as well as the
anxiogenic effects of NMDA treatment (Barbosa et al., 2012;
Herculano et al., 2015). Moreover, rodent nitrergic neurons are activat-
ed after exposure to anxiogenic contexts (Beijamini and Guimarães,
2006), restraint stress (de Oliveira et al., 2000), or ethanol withdrawal
(Bonassoli et al., 2011). This evidence suggests a role for nitric oxide in
long-term stress sensitization, particularly in the consolidation of the
behavioral effects of stressful manipulations. In an attempt to clarify
the issue, here we investigate the participation of nitric oxide in the ini-
tiation and consolidation of a delayed behavioral effect of alarm sub-
stance in zebraﬁsh.
2. Methods
2.1. Animals
123 adult (~4 months) unsexed zebraﬁsh from the striped longﬁn
wild-type phenotype were acquired in a local pet shop and used in
the present experiments; the breeder was licensed for aquacultureunder Ibama's (Instituto Brasileiro do Meio Ambiente e dos Recursos
Naturais Renováveis) Resolution 95/1993. Animals were group-
housed in 40 L tanks, with a maximum density of 25 ﬁsh per tank, for
at least 2 weeks before experiments begun. Tanks were ﬁlled with de-
ionized and reconstituted water at room temperature (28 °C) and a
pH of 7.0–8.0. Lighting was provided by ﬂuorescent lamps in a cycle of
14–10 h (LD), according to standards of care for zebraﬁsh (Lawrence,
2007). Allmanipulationsminimized their potential suffering of animals;
in the absence of speciﬁc Brazilian legislation on the use of ﬁsh in re-
search, manipulations followed the recommendations of the Canadian
Council on Animal Care (Canadian Council on Animal Care, 2005). In ad-
dition, following the recommendations from Sociedade Brasileira de
Neurociências e Comportamento (SBNeC), the National Research Coun-
cil of the National Academy's “Guide for the Care and Use of Laboratory
Animals”. Experimental protocols were approved by UFPA's Comitê de
Ética Em Pesquisa com Animais de Experimentação (CEPAE) under de-
cision 213-14.
2.2. Drug, treatment conditions and exposure
L-NG-nitroarginine methyl ester (L-NAME) hydrochloride was bought
from Sigma-Aldrich (St Louis, MO, USA), dissolved in Cortland's salt so-
lution (Wolf, 1963), and injected intraperitoneally in cold-anesthetised
animals follow the protocol in Kinkel et al. (2010). The role of NO was
tested by pre- or post-treating animals with the injection NOS inhibitor
L-NAME (5.0 mg/kg) in three distinct conditions: L-NAME injection
30 min before stressor (alarm substance) exposure; L-NAME injection
30 min after stressor exposure; and L-NAME injection 90 min after
stressor exposure. The ﬁrst condition is intended to manipulate the ini-
tiation of behavioral sensitization, while the latter conditions are
intended to manipulate the consolidation process.
Animals were divided in groups considering drug treatment condi-
tions, as above, and stressor exposure (i.e., controls [distilled water]
vs. AS-exposed animals). Thus, for each treatment condition four sub-
groups were formed: a) water-exposed and vehicle-injected animals
(CTRL + VEH, n=6–10); b) water-exposed and drug-injected animals
(CTRL + L-NAME, n = 9–13); c) AS-exposed and vehicle-injected ani-
mals (AS+ VEH, n=10–13); and d) AS-exposed and L-NAME-injected
animals (AS + L-NAME, n= 7–13).
Conspeciﬁc alarm substance (AS) is a natural stressor for zebraﬁsh,
and functions to signal injury (potentially caused by predation) to
other members of the shoal (von Frisch, 1938); in this sense, AS expo-
sure falls under the aegis of predator threat models, since the predator
is absent (Kavaliers and Choleris, 2001). AS was obtained as described
elsewhere (Maximino et al., 2014a). Brieﬂy, 6 animals were collectively
transferred to an exposure tank (1.5 L) for 10 min for acclimation.
Another donor animal was cold-anesthetized and euthanized by
beheading, and the excess blood was removed with absorbent cotton
swabs. 15 shallow cuts were made in the trunk epidermis, and the re-
gion was bathed in 10 mL of distilled water; 7 mL from the bathe was
added to the exposure tank water, in which all 6 animals were exposed
for 6min. Control groupswere exposed to distilledwater. After stimulus
delivery and exposure, animals were immediately transferred to a 4 L
tank with fresh water (i.e., free from alarm substance), in which they
remained for 24 h before being tested in the light/dark preference test.
2.3. Light/dark preference
24 h after stressor exposure animals were individually tested in the
light/dark preference test, a model which analyzes zebraﬁsh explorato-
ry behavior under motivational conﬂict, which has been previously
shown to be mediated by the glutamate-nitric oxide pathway
(Herculano et al., 2015; Maximino et al., 2014b). Animals were individ-
ually transferred to the central compartment of a black and white tank
(15 cm× 10 cm× 45 cmh× d× l) for a 3-min. Acclimation period, after
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animal was allowed to freely explore the apparatus for 15 min. The fol-
lowing variables were manually recorded by an observer blind to
treatment:
Time on thewhite compartment: the time spent in thewhite portion
of the tank (in s);
Entries in white compartment: the number of entries the animal
makes in the white compartment in the whole session;
Duration of entries in the white compartment: the average time
spent in the white compartment per entry.
Risk assessment: the number of “risk assessment” events, deﬁned as
a fast (b1 s) entry in thewhite compartment followed by re-entry in
the black compartment, or as a partial entry in the white compart-
ment (i.e., the pectoral ﬁn does not cross the midline).
Erratic swimming: the number of “erratic swimming” events, de-
ﬁned as a zig-zag, fast, unpredictable course of swimming of short
duration.
Thigmotaxis: the duration of thigmotaxis events in the white com-
partment (in s), deﬁned as swimming in a distance of 2 cm or less
from the white compartment's walls.
Freezing: the proportional duration of freezing events (in s), deﬁned
as complete cessation of movements with the exception of eye and
opercular movements.
2.4. Statistical analysis
Results were analyzed using 2 (treatment) × 2 (drug dose) analyses
of variance (ANOVA) followed by Tukey's HSD post-hoc tests. Results
from these statistical analyses were considered signiﬁcant when
p b 0.05 or labeled “NS” (non-signiﬁcant) otherwise. To approach ho-
moscedasticity, entry durationswere log-transformed, and freezing du-
rations were square-root-transformed.
3. Results
3.1. Treatment with L-NAME 30 min before AS exposure does not block
behavioral sensitization in the light/dark preference test
We ﬁrst analyzed the effects of pre-treatment with L-NAME 30 min
before AS exposure (timepoint 0′ on Fig. 1A). A main effect of treatment
(control vs. AS; F1, 37 = 8.66, p = 0.005) but not drug dose (0 vs.
5 mg/kg; F1, 37 = 0.052, NS) or for the interaction term (F1, 37 = 1.759,
NS) on the time in the white compartment was observed (Fig. 1B).
Post-hoc analysis revealed statistically signiﬁcant differences between
CTRL + VEH and both AS-treated groups, as well as between CTRL + L-
NAME and both AS-treated groups (p b 0.05).
Neither treatment (F1, 37=0.2821, NS) nor drug dose (F1, 37=2.712,
NS) or the interaction term (F1, 37 = 0.1614, NS) affected the number of
entries in the white compartment (Fig. 1C). A main effect of treatment
was observed on the duration of entries in the white compartment
(F1, 37 = 6.832, p = 0.0129), without an effect of drug dose (F1, 37 =
2.614, NS) or the interaction term (F1, 37=0.3169, NS). Post-hoc analysis
detected a difference between CTRL + VEH and AS + L-NAME groups
(Fig. 1D; p b 0.05).
A main effect of treatment (F1, 37 = 23.67, p b 0.0001), but not drug
dose (F1, 37 = 1.266, NS) or the interaction term (F1, 37 = 0.3787, NS),
was observed in risk assessment (Fig. 1E); the post-hoc analysis uncov-
ered differences between CTRL + VEH and AS + VEH (p b 0.05),
CTRL + VEH and AS + L-NAME (p b 0.01), CTRL + L-NAME and
AS + VEH (p b 0.05) and CTRL + L-NAME and AS + L-NAME (p b 0.01).
Similarly, a main effect of treatment (F1, 37 = 11.99, p = 0.0013), but
not drug dose (F1, 37 = 0.045, NS), was found in erratic swimming
(Fig. 1F), for which an interaction between treatment and drug dosewas also absent (F1, 37 = 2.591, NS); post-hoc analysis revealed differ-
ences between CTRL + VEH and both AS-exposed groups (p b 0.01)
and between CTRL + L-NAME and both AS-exposed groups (p b 0.05).
A main effect of treatment (F1, 37 = 10.99, p b 0.0021), but not
drug dose (F1, 37 = 0.912, NS) nor the interaction between variables
(F1, 37 = 0.3536, NS), was observed in thigmotaxis (Fig. 1G); the post-
hoc analysis uncovered differences between both CTRL groups
and both AS-exposed groups (p b 0.05). Finally, no effects of treatment
(F1, 37 = 2.791, NS), drug dose (F1, 37 = 0.066, NS) or the interaction
term (F1, 37 = 0.0898, NS) were observed on freezing (Fig. 1H).
3.2. Treatmentwith L-NAME30min after AS exposure blocks the sensitization
of scototaxis and risk assessment
The timecourse for the analysis of the effects of treatment with L-
NAME 30 min after AS exposure is shown in Fig. 2A. A main effect of
treatment (F1, 45 = 4.61, p = 0.0372) was observed on the time on
the white compartment (Fig. 2B), and a treatment x drug dose
interaction was observed (F1, 45 = 19.7, p b 0.0001); post-hoc analysis
uncovered statistically signiﬁcant differences between CTRL + VEH
and AS + VEH, CTRL + L-NAME and AS + VEH, and AS + VEH and
AS + L-NAME (p b 0.05).
Again, no signiﬁcant effects of treatment (F1, 45 = 1.369, NS), drug
dose (F1, 45 = 3.908, NS), or the interaction term (F1, 45 = 0.822, NS)
was observed on the number of entries on the white compartment
(Fig. 2C). An effect of treatment (F1, 45 = 6.348, p = 0.0154) and a
drug x treatment interaction (F1, 45 = 6.353, p = 0.0153) were ob-
served on the duration of entries in the white compartment (Fig. 2D),
and post-hoc analysis uncovered differences between CTRL + VEH
and AS + VEH, CTRL + L-NAME and AS + VEH, and AS + VEH and
AS + L-NAME (p b 0.05).
Main effects of treatment (F1, 45)= 6.001, p= 0.018) and drug dose
(F1, 45= 5.572, p= 0.0226), aswell as an interaction between variables
(F1, 45= 17.16, p=0.0001)were observed on risk assessment (Fig. 2E).
Post-hoc analysis uncovered statistically signiﬁcant differences be-
tween CTRL + VEH and AS + VEH, CTRL + L-NAME and AS + VEH,
and AS + VEH and AS + L-NAME (p b 0.005).
A treatment effect (F1, 45 = 16.32, p = 0.0002), but not a drug
(F1, 45 = 0.4252, NS) nor an interaction (F1, 45 = 1.284, NS) effect, was
observed on erratic swimming (Fig. 2F); post-hoc analysis showed
differences between both CTRL groups and both AS-exposed groups
(p b 0.05). Similarly, a main effect of treatment (F1, 45 = 61.95, p b
0.0001), but not drug dose (F1, 45 = 0.127, NS) or of the interaction be-
tween variables (F1, 45 = 0.4669, NS), was observed in thigmotaxis
(Fig. 2G), with differences between both CTRL groups and both AS-
exposed groups (p b 0.05). No effects of treatment (F1, 37 = 0.0138,
NS), drug dose (F1, 37 = 0.1566, NS) or the interaction term (F1, 37 =
1.125, NS) were observed on freezing (Fig. 2H).
3.3. Treatmentwith L-NAME90min after AS exposure blocks the sensitization
of risk assessment, erratic swimming and thigmotaxis
Fig. 3A shows the timecourse for the assessment of effects of L-NAME
injected 90 min after AS exposure. A main effect of treatment (F1, 34 =
7.755, p= 0.0087), but not of drug dose (F1, 34 = 0.3783, NS) nor an in-
teraction effect (F1, 34=0.8155, NS),was observed on timeon thewhite
compartment (Fig. 3B),with statistically signiﬁcant differences between
both CTRL groups and both AS-exposed groups (p b 0.05) uncovered by
post-hoc analysis. No effects of treatment (F1, 34= 0.04685, NS) or drug
dose (F1, 34 = 0.0145, NS), nor an interaction effect (F1, 34 = 0.36, NS)
were observed on entries on the white compartment (Fig. 3C). A main
effect of treatment (F1, 34 = 7.53, p = 0.0096), but not drug dose
(F1, 34 = 0.7846, NS) nor an interaction effect (F1, 34 = 2.743, NS),
was observed for the duration of entries on white (Fig. 3D), with post-
hoc analysis detecting differences between both CTRL groups, the
AS + L-NAME and the AS + VEH group.
Fig. 2.Treatmentwith L-NAME30min after AS exposure blocks its delayed effects on scototaxis and risk assessment. (A) Timecourse of this experiment: exposure towater (CTRL) or alarm
substance (AS) always occurred at time 0 and was preceded by injection with vehicle (VEH) or L-NAME 30 min after stress (+30′). Animals were tested in the light/dark preference test
24 h after CTRL/AS exposure, and the following variables were measured: (B) time on the white compartment; (C) frequency of entries in white compartment; (D) duration of entries in
the white compartment; (E) frequency of risk assessment events; (F) frequency of erratic swimming events; (G) duration of thigmotaxis; and (H) duration of freezing events. *, p b 0.05.
Fig. 1. Exposure to alarm substance (AS) for 6 min increases anxiety-like behavior 24 h after stressor delivery, an effect which is not blocked by pretreatment with L-NAME 30 min before
stress. (A) Timecourse of this experiment: exposure to water (CTRL) or alarm substance (AS) always occurred at time 0 and was preceded by injection with vehicle (VEH) or L-NAME
30 min before stress (−30′). Animals were tested in the light/dark preference test 24 h after CTRL/AS exposure, and the following variables were measured: (B) time on the white
compartment; (C) frequency of entries in white compartment; (D) duration of entries in the white compartment; (E) frequency of risk assessment events; (F) frequency of erratic swim-
ming events; (G) duration of thigmotaxis; and (H) duration of freezing events. *, p b 0.05.
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Fig. 3. Treatmentwith L-NAME 90min after AS exposure blocks its delayed effects on erratic swimming, thigmotaxis and risk assessment. (A) Timecourse of this experiment: exposure to
water (CTRL) or alarm substance (AS) always occurred at time 0 andwas preceded by injectionwith vehicle (VEH) or L-NAME 90min after stress (+90′). Animals were tested in the light/
dark preference test 24 h after CTRL/AS exposure, and the following variables were measured: (B) time on the white compartment; (C) frequency of entries in white compartment;
(D) duration of entries in the white compartment; (E) frequency of risk assessment events; (F) frequency of erratic swimming events; (G) duration of thigmotaxis; and (H) duration
of freezing events. ***, p b 0.001; **, p b 0.01; *, p b 0.05.
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drug treatment (F1, 34 = 0.2734, NS), was observed for risk
assessment (Fig. 3E); an interaction effect was also observed
(F1, 34 = 13.31, p = 0.0009), with post-hoc analysis detecting differ-
ences between both CTRL groups, the AS + L-NAME and the
AS + VEH group. Both an interaction (F1, 34) = 29.91, p b 0.0001)
and a main treatment effect (F1, 34 = 15.95, p = 0.0003), but not a
main effect of drug (F1, 34 = 0.3047, p = 0.5845), were found for er-
ratic swimming (Fig. 3F); post-hoc analysis uncovered differences
between CTRL + VEH and AS + VEH as well as AS + VEH and
AS + L-NAME groups.
Main effects for treatment (F1, 34 = 16.61, p = 0.0003) and
drug dose (F1, 34 = 172.2, p b 0.0001), as well as an interaction
effect (F1, 34 = 12.33, p = 0.0013) were observed on thigmotaxis
(Fig. 3G); differences were found between CTRL + VEH and AS + VEH
(p b 0.0001), CTRL + VEH and AS + L-NAME (p b 0.0001), CTRL + L-
NAME and AS + VEH (p b 0.0001), and AS + VEH and AS + L-NAME
(p b 0.001). Finally, no main effects of treatment (F1, 34 = 0.2191, NS)
or drug (F1, 34 = 0.7069, NS), nor an interaction effect (F1, 34 = 0.589,
NS), were observed on freezing (Fig. 3H).4. Discussion
In the present article, we demonstrated that AS exposure produces a
delayed (N24 h) sensitization of behavior in the light/dark preference
test, increasing scototaxis, risk assessment, erratic swimming and thig-
motaxis. Moreover, we demonstrated that blocking NO synthesis with
L-NAMEblocks the consolidation, but not the initiation, of this behavior-
al sensitization, and that different timewindows are involved in theNO-
dependent sensitization of scototaxis vs. erratic swimming andthigmotaxis. Thus, treatment with L-NAME 30 min after AS exposure
blocked the delayed sensitization of scototaxis and risk assessment,
while treatment with the same drug 90 min after AS exposure blocked
the sensitization of risk assessment, erratic swimming and thigmotaxis.
While scototaxis (dark preference) is the most widely tested vari-
able in the light/dark preference test (e.g., Norton et al., 2011; Sison
andGerlai, 2011;Wong et al., 2012), it is not the only observable behav-
ior in this task, and indeed “ethological” variables such as erratic swim-
ming, freezing, thigmotaxis and risk assessment have been shown to be
differentially affected by experimental manipulations and pharmaco-
logical treatments (Blaser et al., 2010; Maximino et al., 2010a, 2014b;
Blaser and Peñalosa, 2011). Previouswork demonstrated that dark pref-
erence is affected by different stressful manipulations, including acute
exposure to AS (Mansur et al., 2014;Maximino et al., 2014a) and chron-
ic unpredictable stress (Chakravarty et al., 2013). The effects of AS on
scototaxis were observed immediately after exposure in both cases
(Mansur et al., 2014; Maximino et al., 2014a); in the present work, we
demonstrate that AS exposure can also produce a delayed behavioral ef-
fect on this measure, potentiating the anxiogenic character of the
apparatus.
While scototaxis and the “ethological”measurements are sometimes
considered equivalent, there is evidence that theymight represent differ-
ent aspects of anxiety-like behavior. A multivariate analysis of drug ef-
fects identiﬁed three relevant clusters representing “avoidance”
(scototaxis and thigmotaxis), “risk taking” (risk assessment and erratic
swimming) and “fear” (freezing) (Maximino et al., 2014b). While freez-
ing has also been interpreted as having “risk assessment”-like functions
in the light/dark test (Blaser et al., 2010), AS increases freezing without
affecting risk assessment when animals are tested immediately after ex-
posure (Maximino et al., 2014a). While erratic swimming, thigmotaxis
and risk assessment were all sensitized by AS exposure in the present
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are under the control of the glutamate-NO pathway, as NMDA treatment
decreases the ﬁrst and increases the latter and L-NAME blocks this effect
(Barbosa et al., 2012; Herculano et al., 2015). Acute restraint stress in-
creases erratic swimming in zebraﬁsh (Ghisleni et al., 2012), while freez-
ing is increased after chronic unpredictable stress (Chakravarty et al.,
2013). Erratic swimming is also affected by sustained threat, as predator
exposure for 72 h increases this variable in the novel tank test (Stewart
et al., 2014b). In the present experiments, L-NAME did not block the de-
layed effects of AS on erratic swimming and thigmotaxis when adminis-
tered 30 min after stressor exposure, but was effective when
administered 90 min after AS delivery — the opposite pattern that was
observed in scototaxis. NMDA antagonists have been shown to block
the initiation of sensitized responses to predator threat in rodents
(Blundell et al., 2005), which suggest that intensely stressful events
lead to a ﬁrst wave of glutamate release that will initiate NO-dependent
consolidation of some, but not all, effects in a short time window. A sec-
ond wave of NO – perhaps controlled by different nitric oxide synthase
isoforms –would then lead to the consolidation of other effects. Since L-
NAME by itself did not affect behavior in the light/dark test in the present
experiment, it is suggested that nitrergic activation speciﬁcally underlies
the sensitization of anxiety-like behavior.
An involvement of NO has been suggested before in mediating the
effects of NMDA on zebraﬁsh scototaxis (Barbosa et al., 2012;
Herculano et al., 2015); in that paper, the same dose of L-NAME used
in the present experimentswas not able to inhibit anxiety-like behavior
by itself.While a speciﬁc role for NO in controlling anxiety-like behavior
regardless of the stimulus which increases it cannot be discarded, possi-
ble increases in nitrergic tone at themoment of behavioral testing were
unlikely to be affected by L-NAME treatment at the timepoints used in
this study. Taken in conjunction with the results reported regarding
the NMDA-NO pathway in zebraﬁsh scototaxis (Barbosa et al., 2012;
Herculano et al., 2015), these observations suggest that NO canmediate
increases in anxiety caused by highly stressful stimuli that lead to mas-
sive glutamate release. The timecourse of behavioral alterations and
pharmacological effects suggest that acute predator threat leads to
two stages of nitrergic signaling, one peaking 30 min after exposure
and a second, delayed one peaking 90 min after exposure; the relation-
ship between these peaks and upstream signals (e.g., glutamate, seroto-
nin) and speciﬁcNOS isoforms (inducible or constitutive) awaits further
studies.
NO usually produces biphasic, dose-dependent effects in animal
models, including zebraﬁsh scototaxis (Herculano et al., 2015), and
the effects of L-NAME observed in the present experiments could repre-
sent a point in the dose–response curve; it is plausible, then, that at
other doses L-NAME could block the initiation of the sensitized re-
sponses after AS exposure. Further experiments using other doses are
needed to disentangle the hypotheses.
Overall, our results demonstrate for the ﬁrst time that AS can sensi-
tize zebraﬁsh behavior with a 24 h delay after stressor exposure, a long-
term stress sensitization effect that is relevant for PTSD and other
TRSDs. Moreover, our results suggest that NO participates in the consol-
idation of a sensitization of scototaxis immediately after stress and er-
ratic swimming and thigmotaxis after that; moreover, we suggest that
NO does not participate in the initiation of sensitization, but further
experiments are needed to conﬁrm this ﬁnding. These results have im-
portant implications for understanding the pathophysiology of PTSD
and can suggest prophylactic peritraumatic treatments for exposed
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